Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
European Journal of Gastroenterology & Hepatology|October 24, 2014
Entecavir has high efficacy and safety in white patients with chronic hepatitis B and comorbiditiesMaria Buti, Rosa M Morillas, Juan Pérez, et al.
Journal of Clinical Gastroenterology|June 23, 2016
Altered Underlying Renal Tubular Function in Patients With Chronic Hepatitis B Receiving Nucleos(t)ide Analogs in a Real-World Setting: The MENTE StudySonia Rodríguez-Nóvoa, Javier García-Samaniego, Martín Prieto, et al.
Gastroenterologia Y Hepatologia|December 30, 2022
Long-term follow-up of HCV-infected patients with end-stage chronic kidney disease after sustained virological response with direct-acting antiviral therapyJoan Martínez-Campreciós, Mar Riveiro-Barciela, Raquel Muñoz-Gómez, et al.
Journal of Hepatology|August 27, 2017
Clinical outcomes of patients undergoing antiviral therapy while awaiting liver transplantationJuan Manuel Pascasio, Carmen Vinaixa, María Teresa Ferrer, et al.
Gastroenterologia Y Hepatologia|February 2, 2023
mTOR inhibitors a potential predisposing factor for chronic hepatitis E: Results from the prospective collaborative CHES study (Chronic Hepatitis EScreening in patients with immune impairment and increased transaminases levels)Mar Riveiro-Barciela, Luisa Roade, Joan Martínez-Camprecios, et al.
The Lancet. Infectious Diseases|February 25, 2016
Ledipasvir and sofosbuvir plus ribavirin in patients with genotype 1 or 4 hepatitis C virus infection and advanced liver disease: a multicentre, open-label, randomised, phase 2 trialMichael Manns, Didier Samuel, Edward J Gane, et al.
Transplant International : Official Journal of the European Society for Organ Transplantation|June 14, 2017
Efficacy and safety of daclatasvir-based antiviral therapy in hepatitis C virus recurrence after liver transplantation. Role of cirrhosis and genotype 3. A multicenter cohort studyMagdalena Salcedo, Martín Prieto, Lluís Castells, et al.
Revista Espanola De Enfermedades Digestivas|April 26, 2022
Effects of everolimus plus minimized tacrolimus on kidney function in liver transplantation: REDUCE, a prospective, randomized controlled studyMiguel Gómez-Bravo, Martín Prieto Castillo, Miquel Navasa, et al.
Hepatology (Baltimore, Md.)|February 8, 2017
Treatment of hepatitis C virus infection in patients with cirrhosis and predictive value of model for end-stage liver disease: Analysis of data from the Hepa-C registryCarlos Fernández Carrillo, Sabela Lens, Elba Llop, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 9, 2017
High efficacy of Sofosbuvir plus Simeprevir in a large cohort of Spanish cirrhotic patients infected with genotypes 1 and 4Zoe Mariño, Juan M Pascasio-Acevedo, Adolfo Gallego, et al.
Pageof 10